ORIGINAL RESEARCH
Published on 23 May 2025
Lenvatinib versus bevacizumab when combined with PD-1/L1 inhibitor and hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma
doi 10.3389/fimmu.2025.1573098
- 291 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immunology and Therapeutic Innovations in Hepatocellular Carcinoma: Exploring Immune Evasion and Beyond
Immunology and Therapeutic Innovations in Hepatocellular Carcinoma: Exploring Immune Evasion and Beyond
71
Total downloads
1,077
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: